As of 2024-12-14, the Relative Valuation of Affluent Medical SAS (AFME.PA) is (2.32) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.36 EUR, the upside of Affluent Medical SAS based on Relative Valuation is -270.9%.
The range of the Relative Valuation is (2.03) - (2.54) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.9x - 5.8x | 4.8x |
| Forward P/E multiples | 4.6x - 7.0x | 5.8x |
| Fair Price | (2.03) - (2.54) | (2.32) |
| Upside | -248.9% - -286.8% | -270.9% |
| Date | P/E |
| 2024-11-21 | -3.80 |
| 2024-11-20 | -3.81 |
| 2024-11-19 | -3.89 |
| 2024-11-18 | -3.94 |
| 2024-11-15 | -3.93 |
| 2024-11-14 | -3.85 |
| 2024-11-13 | -3.85 |
| 2024-11-12 | -4.04 |
| 2024-11-11 | -4.08 |
| 2024-11-08 | -4.23 |
| 2024-11-07 | -4.14 |
| 2024-11-06 | -4.16 |
| 2024-11-05 | -4.12 |
| 2024-11-04 | -4.17 |
| 2024-11-01 | -4.31 |
| 2024-10-31 | -4.31 |
| 2024-10-30 | -4.12 |
| 2024-10-29 | -4.26 |
| 2024-10-28 | -3.87 |
| 2024-10-25 | -3.88 |
| 2024-10-24 | -3.84 |
| 2024-10-23 | -3.89 |
| 2024-10-22 | -3.94 |
| 2024-10-21 | -3.94 |
| 2024-10-18 | -4.01 |
| 2024-10-17 | -3.84 |
| 2024-10-16 | -3.84 |
| 2024-10-15 | -3.78 |
| 2024-10-14 | -3.89 |
| 2024-10-11 | -3.89 |
| 2024-10-10 | -3.92 |
| 2024-10-09 | -4.06 |
| 2024-10-08 | -4.04 |
| 2024-10-07 | -4.08 |
| 2024-10-04 | -4.02 |
| 2024-10-03 | -3.95 |
| 2024-10-02 | -4.11 |
| 2024-10-01 | -3.94 |
| 2024-09-30 | -4.31 |
| 2024-09-27 | -4.33 |
| 2024-09-26 | -4.32 |
| 2024-09-25 | -4.31 |
| 2024-09-24 | -4.33 |
| 2024-09-23 | -4.25 |
| 2024-09-20 | -4.18 |
| 2024-09-19 | -4.32 |
| 2024-09-18 | -4.27 |
| 2024-09-17 | -4.39 |
| 2024-09-16 | -4.31 |
| 2024-09-13 | -4.33 |